Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1763f7f78d01cad638210d060676591a |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2750-14143 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1709 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-39 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-0075 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-39 |
filingDate |
2012-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9b39f489d4f82f422b04d54a043019e0 |
publicationDate |
2013-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2013158103-A1 |
titleOfInvention |
Method of Tissue-Selective Targeted Gene Transfer |
abstract |
The present invention relates to methods of delivering a gene, such as a therapeutic gene, to a desired area of stroma of a cornea that involves removing the corneal epithelium and dehydrating the cornea. Certain aspects of the present invention relate to methods of treating corneal scarring by delivering a TGFβ-antagonizing gene packaged in a viral vector. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11713337-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11116850-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022212790-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2022204562-A1 |
priorityDate |
2011-11-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |